Key to the Treatment of Primary Aldosteronism in Secondary Hypertension: Subtype Diagnosis

Curr Hypertens Rep. 2023 Dec;25(12):471-480. doi: 10.1007/s11906-023-01269-x. Epub 2023 Oct 3.

Abstract

Purpose of review: Primary aldosteronism (PA) is a leading global cause of secondary hypertension. Subtyping diagnosis of PA is the key to surgery, but accurate classification of PA is crucial but challenging in clinical diagnosis and treatment. The purpose of this review is to provide a summary of current literature and propose subtyping diagnosis flow chart to help us classify PA quickly and accurately.

Recent findings: Early diagnosis and accurate typing are essential for the timely treatment and appropriate management of PA. For most patients, adrenal venous sampling (AVS) is the central choice for typing diagnosis, but AVS is invasive and difficult to promote effectively. CT can help identify unilateral typical adenomas in select patients to avoid AVS. New radionuclide imaging has shown value in the diagnosis and classification of PA, which distinguishes adrenocortical hyperplasia from adenoma and can replace AVS in some patients. Accurately diagnosing unilateral PA is crucial for determining the appropriate treatment strategy for PA. The simple flow chart of PA subtyping diagnosis based on the current literature needs to be verified and evaluated by follow-up researches.

Keywords: AVS; PET/CT; Primary aldosteronism; Secondary hypertension; Subtype diagnosis.

Publication types

  • Review

MeSH terms

  • Adenoma* / complications
  • Adrenal Gland Neoplasms* / complications
  • Adrenal Gland Neoplasms* / diagnosis
  • Adrenal Gland Neoplasms* / therapy
  • Adrenalectomy / adverse effects
  • Aldosterone
  • Humans
  • Hyperaldosteronism* / complications
  • Hyperaldosteronism* / diagnosis
  • Hyperaldosteronism* / therapy
  • Hypertension* / diagnosis
  • Hypertension* / etiology
  • Hypertension* / therapy

Substances

  • Aldosterone